Key result
LVEF of 42% optimally predicts ventricular arrhythmias and all-cause mortality in cardiac sarcoidosis.
Why the study?
What is the optimal LVEF cutoff for predicting ventricular arrhythmias and all-cause mortality in patients with cardiac sarcoidosis?
What is the optimal LVEF cutoff for predicting ventricular arrhythmias and all-cause mortality in patients with cardiac sarcoidosis?
An LVEF cutoff of 42%, along with prior VA and scar on CMR or PET, are strong predictors of future ventricular arrhythmias and mortality in patients with cardiac sarcoidosis.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“To our knowledge, this is the first study to determine the optimal LVEF cutoff for risk stratification in patients with definite diagnosis of [cardiac sarcoidosis]. [This cutoff determination] suggests that moderate to severe left ventricular dysfunction is not required for adverse outcomes to occur.”
LVEF 42% may aid VA risk stratification in cardiac sarcoidosis; hypothesis-generating and requires prospective validation.
Among patients with CS, a mild reduction in LVEF of 42% was identified as the optimal cutoff for predicting VA and all-cause mortality. Prior VA and scar by CMR or PET are strong risk factors for future VA and all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Hutt et al. (2023) studied this question. A left ventricular ejection fraction of 42% is the optimal cutoff for predicting ventricular arrhythmias and all-cause mortality in patients with cardiac sarcoidosis.
Synapse has enriched 10 related papers. Consider them for comparative context: